Workflow
硫糖铝原料药
icon
Search documents
海森药业上半年净利润6079万元 国际化战略与研发投入双轮驱动
Quan Jing Wang· 2025-08-15 05:44
Core Viewpoint - Zhejiang Haisen Pharmaceutical Co., Ltd. reported a steady growth in its half-year performance, with revenue of approximately 242 million yuan, a year-on-year increase of 14.93%, and a net profit of about 60.79 million yuan, up 4.74% year-on-year, attributed to its international layout, R&D innovation, and market advantages of core products [1] Group 1: Financial Performance - The company's revenue from raw materials reached 207 million yuan, a year-on-year increase of 13.94%, while the intermediate business revenue was 28.76 million yuan, up 29.24% [2] - The overseas sales revenue grew by 53.04%, accounting for 55.61% of total revenue, reflecting the success of the company's international strategy [2] Group 2: R&D and Innovation - Haisen Pharmaceutical increased its R&D investment to 17.71 million yuan, a 52.83% increase year-on-year, representing 7.32% of its revenue, with 17 ongoing projects in various fields [3] - The establishment of the Hangzhou Haisen Drug Research Institute enhances R&D capabilities, and the new pilot workshop supports the transition from laboratory to industrial production [3] Group 3: Strategic Outlook - The company plans to continue its "raw materials + formulations" dual-driven strategy, focusing on core product markets and accelerating the industrialization of ongoing projects [4] - Haisen Pharmaceutical aims to leverage its technological accumulation, quality advantages, and international layout to strengthen its market position in the generic raw materials and specialty formulations sectors [4]
海森药业:首次公开发行股票并在主板上市发行公告
2023-03-26 12:54
浙江海森药业股份有限公司 首次公开发行股票并在主板上市发行公告 保荐人(主承销商):中信证券股份有限公司 特别提示 浙江海森药业股份有限公司(以下简称"海森药业"、"发行人"或"公司") 根据《证券发行与承销管理办法》(证监会令【第 208 号】)(以下简称"《管 理办法》")、《首次公开发行股票注册管理办法》(证监会令【第 205 号】) (以下简称"《注册办法》")、《深圳证券交易所首次公开发行证券发行与承 销业务实施细则》(深证上〔2023〕100 号)(以下简称"《业务实施细则》")、 《深圳市场首次公开发行股票网上发行实施细则》(深证上〔2018〕279 号)(以 下简称"《网上发行实施细则》")及《深圳市场首次公开发行股票网下发行实 施细则(2023 年修订)》(深证上〔2023〕110 号)(以下简称"《网下发行实 施细则》")、《首次公开发行证券承销业务规则》(中证协发〔2023〕18 号) (以下简称"《承销业务规则》")、《首次公开发行证券网下投资者管理规则》 (中证协发〔2023〕19 号)(以下简称"《网下投资者管理规则》")等有关股 票发行上市规则和最新操作指引等相关法律法规、监管规 ...